The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma

Philipp Baumann, Sonja Mandl–Weber, Fuat Oduncu, Ralf Schmidmaier

Experimental Cell Research · 2008 · 122 citations · 29 references

Concepts

References

29